Supportive-expressive group therapy and life extension of breast cancer patients: Spiegel et al. (1989)
Spiegel, D.; Cordova, M.; Speigel, D.
Advances in Mind-Body Medicine 17(1): 38-41
2001
ISSN/ISBN: 1470-3556 PMID: 11270061 Document Number: 530507
Document emailed within 1 workday
Related Documents
Tominaga, T.; Abe, O.; Izuo, M.; Isono, K.; Enomoto, K.; Nishi, M.; Fukami, A.; Muto, T.; Morioka, Y.; Watanabe, H. 1993: Correlations between estrogen receptor and prognostic factors of patients with breast cancer. the Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2171-2176Castiglione-Gertsch, M.; Tattersall, M.; Hacking, A.; Goldhirsch, A.; Gudgeon, A.; Gelber, R.D.; Lindtner, J.; Coates, A.; Collins, J.; Isley, M.; Senn, H.J.; Rudenstam, C.M. 1997: Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group European Journal of Cancer 33(14): 2321-2325
Mitsuyama, S.; Kuroda, Y.; Ohsato, K.; Nakamura, Y.; Murakami, F.; Nishikata, F.; Ikeda, S.; Egami, T.; Mori, A.; Ohe, H. 1996: Administration method and recurrence-preventing effect of medroxyprogesterone acetate (MPA) as a postoperative adjuvant endocrine therapy for stage III breast cancer. Kitakyushu Collaborative Study Group for Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(9): 1153-1160
Ariyoshi, Y. 1999: Recent advances of supportive therapy for cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26 Suppl. 1: 60-69
Crivellari, D. 2002: Results of adjuvant treatments in breast cancer patients over 70 years old: the IBCSG experience. International Breast Cancer Study Group Tumori 88(1 Suppl. 1): S81-S82
Ansquer, Y.; Gautier, C.; Fourquet, A.; Asselain, B.; Stoppa-Lyonnet, D. 1998: Survival in early-onset BRCA1 breast-cancer patients. Institut Curie Breast Cancer Group Lancet 352(9127): 541
Axelsson, C.K.; Andersen, J.A.; Andersen, K.W.; Blichert-Toft, M.; Dombernowsky, P.; Hansen, M.; Krag, C.; Mouridsen, H.T.; Overgaard, M.; Rasmussen, B.B. 1991: Prognosis after surgical treatment of breast cancer. 3. The low-risk group of the DBCG (Danish Breast Cancer Cooperative Group) Ugeskrift for Laeger 153(33): 2276-2279
Liang, X.-f.; Ma, D.-c.; Ding, Z.-y.; Liu, Z.-z.; Guo, F.; Liu, L.; Yu, H.-y.; Han, Y.-l.; Xie, X.-d. 2013: Autologous cytokine-induced killer cells therapy on the quality of life of patients with breast cancer after adjuvant chemotherapy: a prospective study Zhonghua Zhong Liu Za Zhi 35(10): 764-768
Taguchi, T.; Koyama, H.; Yayoi, K.; Wada, T.; Takatsuka, Y.; Sonoo, H.; Morimoto, K.; Tominaga, T.; Abe, R.; Enomoto, K. 1995: Long-term clinical study on TAP-144-SR, an LH-RH agonist depot formulation, in premenopausal patients with advanced or recurrent breast cancer. TAP-144-SR Breast Cancer Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(4): 495-508
Richardson, M.A.; Post-White, J.; Grimm, E.A.; Moye, L.A.; Singletary, S.E.; Justice, B. 1997: Coping, life attitudes, and immune responses to imagery and group support after breast cancer treatment Alternative Therapies in Health and Medicine 3(5): 62-70
Sinaei, F.; Zendehdel, K.; Adili, M.; Ardestani, A.; Montazeri, A.; Mohagheghi, M.Ali. 2017: Association Between Breast Reconstruction Surgery and Quality of Life in Iranian Breast Cancer Patients Acta Medica Iranica 55(1): 35-41
Yoshida, M.; Saji, S.; Takagi, H.; Takeuchi, S.; Tsuda, H.; Nimura, Y.; Mizumoto, R.; Miyazaki, I.; Kobayashi, S.; Noguchi, M. 1993: A comparative study among ftorafur, ftorafur plus tamoxifen, and tamoxifen in adjuvant therapy for breast cancer. the Chubu Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(15): 2325-2333
Hooning, M.J.; van Dongen, J.A.; Went, G. 1991: Changing indications for breast conserving therapy: proportion of patients with operable breast cancer suitable for breast conservation Netherlands Journal of Surgery 43(4): 102-104
Nayir, E.; Bakir Koyuncu, M.; Esin, E.; Turker, I.; Tanriverdi, O.; Uysal, M.; Er, O.; Demir, A.; Tuzel Akman, T.; Nur Pilanci, K.; Paydas, S.; Kocar, M.; Saip, P.; Kilickap, S.; Turhal, S.; Kacan, T. 2017: Attitudes of cancer patients after diagnosis: how cancer affects social life? a Turkish Oncology Group study Journal of Buon: Official Journal of the Balkan Union of Oncology 22(1): 208-213
Letang, B.W. 1977: Coordinated supportive services benefit the breast cancer patient Delaware Medical Journal 49(11): 623-624
Mustacchi, G.; Milani, S.; Pluchinotta, A.; De Matteis, A.; Rubagotti, A.; Perrota, A. 1994: Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer: the G.R.E.T.A. Trial. Group for Research on Endocrine Therapy in the Elderly Anticancer Research 14(5b): 2197-2200
Tangkaratt, S. 2004: Mammographic findings in breast cancer patients, who were treated with breast conserving therapy Journal of the Medical Association of Thailand 87(12): 1439-1443
Mannell, A. 2005: Breast-conserving therapy in breast cancer patients--a 12-year experience South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie 43(2): 28-30; Discussion 30, 32
Lundin, A.C.; Söderkvist, P.; Eriksson, B.; Bergman-Jungeström, M.; Wingren, S. 1999: Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group Cancer Research 59(10): 2332-2334
Fortunato, L.; Drago, S.; Vitelli, C.E.; Santoni, M.; Gucciardo, G.; Cabassi, A.; Farina, M.; La Pinta, M.; Remedi, M.; Pagano, G.; Silipod, T.; Terribile, D.; Stagnitto, D.; Grassi, G.B. 2006: Sentinel lymph node biopsy in breast cancer. Experience of the Rome Breast Cancer Study Group Chirurgia Italiana 58(6): 689-696